Tech Company Financing Transactions
NKGen Biotech Funding Round
On 7/17/2025, NKGen Biotech raised $2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
7/17/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3001 Daimler Street
Santa Ana, CA 92705
USA
Santa Ana, CA 92705
USA
Phone
Website
Email Address
Overview
NKGen Biotech's vision is to become the global leader in natural killer cell therapy. NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Song
Browse more venture capital transactions:
Prev: 7/16/2025: Bedrock Robotics venture capital transaction
Next: 7/17/2025: Anthropic venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs